Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Covington, Louisiana 25 trials found
New Search
Filter
Trial Phase
Study Type
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
PHASE1INTERVENTIONAL Fresno, California +4 more
RECRUITING
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
PHASE2INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
PHASE2, PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)
NAINTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
PHASE1INTERVENTIONAL Santa Monica, California +4 more
RECRUITING
Pancreatic Cancer Detection Consortium
N/AOBSERVATIONAL Phoenix, Arizona +4 more
RECRUITING
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
PHASE1, PHASE2INTERVENTIONAL Fountain Valley, California +4 more
RECRUITING
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
PHASE1INTERVENTIONAL Costa Mesa, California +4 more
RECRUITING
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
PHASE2INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
N/AOBSERVATIONAL Fort Smith, Arkansas +4 more
RECRUITING
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
N/AOBSERVATIONAL Phoenix, Arizona +4 more
RECRUITING
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
NAINTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
PHASE3INTERVENTIONAL Kingman, Arizona +4 more
RECRUITING
Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source
PHASE1, PHASE2INTERVENTIONAL Tampa, Florida +4 more
RECRUITING
Caris Biorepository Research Protocol
N/AOBSERVATIONAL Mobile, Alabama +4 more
RECRUITING
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Vitamin D for Prostate Endocrine Therapy
PHASE3INTERVENTIONAL Newark, Delaware +4 more
RECRUITING
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type